FLUIDIGM CORP (FLDM)
Common Stock
FLUIDIGM CORP
NASDAQ:FLDM (4/5/2022, 7:24:22 PM)
After market: 4.02 +0.31 (+8.36%)3.71
-0.28 (-7.02%)
Company Profile
Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
Company Info
FLUIDIGM CORP
2 Tower Place, Suite 2000
South San Francisco CALIFORNIA 94080
P: 16502666000.0
CEO: Stephen Christopher Linthwaite
Employees: 615
Website: https://www.fluidigm.com/
FLDM News
7 months ago - The Motley FoolWhy SomaLogic Stock Dived by 10% on WednesdayThe market wasn't impressed by the company's announced tie-up with Standard BioTools.
New Trading Symbol (NASDAQ:LAB) Expected to be Effective April 6, 2022 Appoints New Management Team and Additional Board Members with Significant...
SOUTH SAN FRANCISCO, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM) today announced that its stockholders have voted to...
Caligan Partners to Vote “FOR” Casdin and Viking Transaction and All Other Fluidigm Proposals at the Special Meeting to be Reconvened on April 1, 2022 ...
Company Urges ALL Stockholders to Vote “FOR” the Proposals at the Special Meeting Parties to Terminate the Purchase Agreements if Stockholder Approval is...
2 years ago - Comserve Inc.Tissue Culture Reagents Market Global Size, Growth, Dynamic Analysis, And Forecast By 2029FLDM Twits
Here you can normally see the latest stock twits on FLDM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
